Bruno Cazin

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

Michael Hallek, Kirsten Fischer, Guenter Fingerle-Rowson et al. · The Lancet · 2010 · 1.9K citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +10

Chlorambucil in Indolent Chronic Lymphocytic Leukemia

Guillaume Dighiero, Karim Maloum, B Desablens et al. · New England Journal of Medicine · 1998 · 442 citations · Full text

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

M Leporrier, Sylvie Chevret, Bruno Cazin et al. · Blood · 2001 · 393 citations · Full text

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

Claire Dearden, Estella Matutes, Bruno Cazin et al. · Blood · 2001 · 315 citations · Full text

A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

Harriet S. Walter, Simon A. Rule, Martin J.S. Dyer et al. · Blood · 2015 · 262 citations · Full text